, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 9. Expected Benefits for the Company: The company expects to benefit from the opportunity of being more competitive
applying Net Operating Profit after tax deduction criteria and is considered a class 2 transaction under the Announcement of the Acquisition or Disposal, being 15 percent or higher but lower than 50 percent
the par value of the Company after being granted approval from the shareholders’ meeting pursuant to Section 52 of the Public Limited Companies Act B.E. 2535 (as amended). PP Transactions are considered
Crossroads not Page 4 of 5 being consolidated upon the Company’s investment in 1st Phase Development of Crossroads in February 2018, as mentioned previously. Other Business Performance of this part constitutes
compensated by an increase in the accounting and financial outsourcing of 3.85mb, representing an increase of 3.8% We have being appounted by Oracle Netsuite as a reseller in second half of 2019. This
previous year decreased by 34.22 million baht or 35.58 percent mainly due to Euro Asia Total Logistics Company Limited had operating losses Due to being in the initial stages of operation Therefore have a
management team being present. 5. Review the disclosure of the Company in case where there is any connected transaction that may lead to conflict of interest so as to ensure the reasonable transaction and
decrease of Baht 1,815 million or 4.3% from those of 31 December 2016 following the dividend payment of Baht 3,742 million and the profits being generated during the year 2017. In 2006, the Company had
reach 122,000 kiosks nationwide and the total usage amount of Bt32,000mn. The Company focuses on being the leader of payment solutions by 5 digital retail channels strategy. The Company plans to launch
business of the Company. 6. Persons having Interest in the transactions and being not entitled to vote in this agenda of the Meeting of the Board of Directors Mr. Somyos Anantaprayoon*, Ms. Jareeporn